The Effect of Transcranial Direct Current Stimulation on Motor Performance in Healthy Adults

October 6, 2020 updated by: Ariel University

The Effect of Transcranial Direct Current Stimulation Intensity on Motor Performance in Healthy Adults

to investigate the effect of stimulation intensity on motor performance in healthy adults.

Study Overview

Status

Completed

Conditions

Detailed Description

60 healthy subjects were randomly allocated to one of three groups: (a) 20-min of High-Definition transcranial direct current stimulation (HD-tDCS) with an intensity of 2 mA (HD-tDCS 2 mA); (2) 20-min of HD-tDCS with an intensity of 1.5 mA (HD-tDCS 1.5 mA); and (3) 20-min of sham HD-tDCS (HD-tDCS sham). The stimulation was administered noninvasively using an M x N 9-channel high definition transcranial electrical current stimulator from Soterix Medical (New York, NY). The anodal stimulation targeted the right Brodmann area 4 (primary motor cortex) based on HD-Targets brain modelling software (Soterix Medical, New York, NY).

Tests: The non-dominant left arm was tested. The subjects performed a sequential point-to-point movement task on the graphics tablet. Initially, the participants were required to perform 3 sequences without errors to familiarize themselves with the setup, the task and the sequence. Then, they performed the pre-test which consisted of two blocks of 6 sequences, i.e. 12 sequences, with a 30 s break between blocks. Two min after starting the appropriate stimulation, they performed 2 blocks of 6 sequences (identical to the pre-test). After finishing the tDCS stimulation, the participants performed a post-test, which was also identical to the pre-test. The participants returned after 24 hours to perform a retention test, which was equivalent to the pre- and post-tests. Two outcome measures were used: movement time (s) and the reaction time (s) of the reaching movements.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ariel, Israel
        • Ariel University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged between 20 and 35
  • right-hand dominant
  • healthy according to self report

Exclusion Criteria:

  • taking psychiatric medications
  • a history of drug abuse or dependence
  • psychiatric or neurological disorder
  • a history of seizures
  • metal implants in their head
  • musculoskeletal deficits interfering with task performance (proper reaching performance in sitting)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HD-tDCS 2 mA
Single session of 20-min HD-tDCS to the right primary motor cortex with an intensity of 2 mA. The session lasted approximately one hour. The participants returned after 24 hours to perform a retention test.
anodal high definition transcranial direct current stimulation of the right primary motor cortex with an intensity of 2 mA
Experimental: HD-tDCS 1.5 mA
Single session of 20-min HD-tDCS to the right primary motor cortex with an intensity of 1.5 mA. The session lasted approximately one hour. The participants returned after 24 hours to perform a retention test.
anodal high definition transcranial direct current stimulation of the right primary motor cortex with an intensity of 1.5 mA
Sham Comparator: Control
Single session of 20-min of sham HD-tDCS. The session lasted approximately one hour. The participants returned after 24 hours to perform a retention test.
sham stimulation of the right primary motor cortex

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in movement time (s) from baseline to intervention
Time Frame: Baseline (immediately before stimulation), two minutes after starting the stimulation
Time from movement onset (first time the tangential velocity was greater than 5% of the peak tangential velocity) until the end of the movement (the last time the tangential velocity was greater than 5% of the peak tangential velocity). Improved motor performance was indicated by a shorter movement time.
Baseline (immediately before stimulation), two minutes after starting the stimulation
Change in movement time (s) from baseline to posttest
Time Frame: Baseline (immediately before stimulation), immediately post stimulation
Time from movement onset (first time the tangential velocity was greater than 5% of the peak tangential velocity) until the end of the movement (the last time the tangential velocity was greater than 5% of the peak tangential velocity). Improved motor performance was indicated by a shorter movement time.
Baseline (immediately before stimulation), immediately post stimulation
Change in movement time (s) from baseline to retention test
Time Frame: Baseline (immediately before stimulation), 24 hours following the stimulation
Time from movement onset (first time the tangential velocity was greater than 5% of the peak tangential velocity) until the end of the movement (the last time the tangential velocity was greater than 5% of the peak tangential velocity). Improved motor performance was indicated by a shorter movement time.
Baseline (immediately before stimulation), 24 hours following the stimulation
Change in movement time (s) from intervention to posttest
Time Frame: Two minutes after starting the stimulation, immediately post stimulation
Time from movement onset (first time the tangential velocity was greater than 5% of the peak tangential velocity) until the end of the movement (the last time the tangential velocity was greater than 5% of the peak tangential velocity). Improved motor performance was indicated by a shorter movement time.
Two minutes after starting the stimulation, immediately post stimulation
Change in movement time (s) from intervention to retention test
Time Frame: Two minutes after starting the stimulation, 24 hours following the stimulation
Time from movement onset (first time the tangential velocity was greater than 5% of the peak tangential velocity) until the end of the movement (the last time the tangential velocity was greater than 5% of the peak tangential velocity). Improved motor performance was indicated by a shorter movement time.
Two minutes after starting the stimulation, 24 hours following the stimulation
Change in movement time (s) from posttest to retention test
Time Frame: immediately post stimulation, 24 hours following the stimulation
Time from movement onset (first time the tangential velocity was greater than 5% of the peak tangential velocity) until the end of the movement (the last time the tangential velocity was greater than 5% of the peak tangential velocity). Improved motor performance was indicated by a shorter movement time.
immediately post stimulation, 24 hours following the stimulation
Change in reaction time (s) from baseline to intervention
Time Frame: Baseline (immediately before stimulation), two minutes after starting the stimulation
Time between when the target appeared in green (changed color from white to green), and movement onset. Improved motor performance was indicated by a shorter reaction time.
Baseline (immediately before stimulation), two minutes after starting the stimulation
Change in reaction time (s) from baseline to posttest
Time Frame: Baseline (immediately before stimulation), immediately post stimulation
Time between when the target appeared in green (changed color from white to green), and movement onset. Improved motor performance was indicated by a shorter reaction time.
Baseline (immediately before stimulation), immediately post stimulation
Change in reaction time (s) from baseline to retention test
Time Frame: Baseline (immediately before stimulation), 24 hours following the stimulation
Time between when the target appeared in green (changed color from white to green), and movement onset. Improved motor performance was indicated by a shorter reaction time.
Baseline (immediately before stimulation), 24 hours following the stimulation
Change in reaction time (s) from intervention to posttest
Time Frame: Two minutes after starting the stimulation, immediately post stimulation
Time between when the target appeared in green (changed color from white to green), and movement onset. Improved motor performance was indicated by a shorter reaction time.
Two minutes after starting the stimulation, immediately post stimulation
Change in reaction time (s) from intervention to retention test
Time Frame: Two minutes after starting the stimulation, 24 hours following the stimulation
Time between when the target appeared in green (changed color from white to green), and movement onset. Improved motor performance was indicated by a shorter reaction time.
Two minutes after starting the stimulation, 24 hours following the stimulation
Change in reaction time (s) from posttest to retention test
Time Frame: immediately post stimulation, 24 hours following the stimulation
Time between when the target appeared in green (changed color from white to green), and movement onset. Improved motor performance was indicated by a shorter reaction time.
immediately post stimulation, 24 hours following the stimulation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Silvi Frenkel-Toledo, Ariel University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 11, 2019

Primary Completion (Actual)

February 10, 2020

Study Completion (Actual)

February 10, 2020

Study Registration Dates

First Submitted

September 23, 2020

First Submitted That Met QC Criteria

October 6, 2020

First Posted (Actual)

October 8, 2020

Study Record Updates

Last Update Posted (Actual)

October 8, 2020

Last Update Submitted That Met QC Criteria

October 6, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • AU-HEA-SFT-20190326

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The datasets (Study Protocol, Statistical Analysis Plan, Informed Consent Form, Analytic Code generated during and/or analyzed during the current study) are available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on HD-tDCS 2 mA

Subscribe